Member Info for Chelsea11

Retreat of the SP here recently has been disappointing to see but hardly surprising given what’s going on in the would currently and it’s clearly not the only stock to take a battering.

However, a thumping Divi landed today in my account offering compensation for investment here.

I’d be more concerned for the future of Scancell’s melanoma therapies if there was a procession of high value deals being done specifically in that arena and comparable to the same targets / patients. But they’re not, are they.

By the time of the AACR Conference (April 17-22), I believe the Company will have MHRA clearance in the bag for Phase 3 iSCIB1+

It will have been 60 days tomorrow since FDA clearance was formally announced and that I believe, is significant.

No worries Berm and thanks for acknowledgment.

You may need to copy the whole link and paste into your browser bar.

April 21st

https://www.abstractsonline.com/pp8/#!/21436/presentation/12110

Sure, agree, no one knows until an RNS lands but given FDA clearance already in hand, I’d be massively disappointed if it’s months fro now before the same arrives from MHRA / EMA.

Hi Chester. You might be right but given FDA clearance already in the bag, why do you think it could be months for the same from MHRA / EMA?

MHRA clearance for iSCIB1+ would be my bet. I also wonder whether that is a key required (together with in-hand FDA clearance) to unlock a partnership / funding agreement already on the table). MHRA clearance must be close.

HAGW

Yeah when GlymabT was created there was lots of discussion about the possible sale of that to fund the other clinical trials, SCIB, Modi etc. Maybe the leadership plan is the opposite. Sell Immunobody and keep / develop the mAb portfolio.

Perhaps there will be a change of name RNS tomorrow morning.

Scanmab 😁

Vascular - thanks.

“Scale-up” to me can only mean one thing and that is intent to widen the remit of CVLP to include more Clinical Trials. It must surely be about getting more folks through doors and funnelled into screening.

Sidneyboz - not aimed at you pal and I know you’re a LTH. The reality here is we need some news directly from the Company and the CMO attendance at WNC will very likely be of zero benefit to anyone invested here - imo.

This subject line is now equally as tedious, boring and inconsequential as “ Yahoo .why Scancell share price is climbing ?”

Time to pick some winners at Cheltenham.

All just smoke and mirrors imo

Dunno about that but let’s hope we soon have something much more interesting to discuss!

“ The main thread of our inaugural conference this year is science and the role it has in shaping: i) the policy environment; ii) Innovation; and iii) the consumer.

We cannot solve the smoking problem in three days. But we can create the conditions for better decisions by ensuring the right people are in the same conversation”

It’s about harm reduction.

Would hope it will bounce back in the short term but the escalating tensions in the Middle East will likely put the brakes on that. Market wide impact and a blanket of uncertainty and the jitters, regardless of individual company performance imo.

Reminder that Vicon are at the 2026 Game Developers Conference in San Francisco w/c 9th March. Hopefully some output on YouTube at some point (and of course future sales generated).

Both hype and fashion can be very powerful movers and shakers.

It has happened here before. Think Covidity and Sky News.

And lots being sold too!